Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population

Zhiyuan Wu1, Hanqiang Jiang, Lei Zhang

  • 1Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.

Plos One
|October 31, 2012
PubMed
Abstract

Insights

RNF213 gene mutations significantly increase Moyamoya disease risk in Han Chinese. The R4810K mutation is linked to ischemic MMD, while A4399T is associated with hemorrhagic MMD, highlighting genetic heterogeneity.

Area of Science:

  • Genetics
  • Neurology
  • Cerebrovascular Diseases

Background:

  • Moyamoya disease (MMD) is a rare cerebrovascular disorder causing progressive artery occlusion.
  • Genetic factors are increasingly implicated in MMD etiology.
  • Previous studies linked the RNF213 gene to MMD in Japanese populations.

Purpose of the Study:

  • To investigate the association between RNF213 gene mutations and MMD susceptibility in the Chinese Han population.
  • To validate the R4810K mutation and identify other RNF213 mutations in this cohort.

Main Methods:

  • A case-control study was conducted with 170 MMD cases and 507 controls.
  • Genotyping of the RNF213 R4810K mutation was performed.
  • Genomic sequencing was used to identify other RNF213 variants.

Main Results:

  • The RNF213 R4810K mutation was significantly more frequent in MMD cases (13%) than controls (0.4%), increasing MMD risk (OR=36.7).
  • R4810K allele frequency differed between ischemic and hemorrhagic MMD subtypes.
  • Eight novel RNF213 variants were identified, including A4399T, which was associated with MMD (OR=2.0), particularly hemorrhagic MMD (OR=2.8).

Conclusions:

  • RNF213 mutations are associated with MMD susceptibility in Han Chinese.
  • The R4810K mutation is linked to ischemic MMD, while A4399T is associated with hemorrhagic MMD.
  • The identification of novel variants underscores the genetic heterogeneity of MMD.